久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Infinity Announces Start of Two IPI-549 Trials for Solid Tumors americanpharmaceuticalreview
    September 05, 2019
    Infinity Pharmaceuticals announced the initiation of two clinical trials for IPI-549, a first-in-class, oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through ...
PharmaSources Customer Service